Associate Director, FP&A — Biotech Growth & Equity

Lyell-Immunopharma,-Inc.

San Francisco (CA)

On-site

USD 170,000 - 210,000

Full time

2 days ago
Be an early applicant
Application generator

Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.

Get past ATS filters

Benefits offered by this job

Equity incentive plan

Job summary

Lyell Immunopharma, Inc. is seeking an Associate Director, FP&A to lead budgeting, forecasting, monthly reporting, and financial modeling in support of a fast‑growing clinical‑stage company.

You will partner with R&D, Clinical, G&A, and Commercial teams to track spend, drive KPI insights, and develop driver‑based models for headcount and program costs, while enhancing FP&A processes and systems.

Qualifications

  • Bachelor's degree in Accounting or Finance required.
  • MBA or related advanced degree preferred.
  • 8+ years FP&A, financial planning, or related function experience.
  • 5+ years in biotechnology/pharma with drug development lifecycle knowledge.
  • Experience with budgeting, forecasting, and monthly reporting.

Responsibilities

  • Lead annual budgeting and quarterly forecasting with cross-functional inputs.
  • Own monthly FP&A reporting, KPI measurement, and variance analysis.
  • Track spend with R&D, Clinical, G&A, Commercial to identify key cost drivers.
  • Develop driver-based financial models linking headcount and expenses to performance.
  • Lead headcount and operating expense planning in collaboration with HR and leaders.
  • Support long-range planning with cross-functional input and timely submissions.
  • Improve FP&A systems, data integration, and forecasting methodologies.
  • Coordinate with Accounting to align forecasts with actual results.
  • Provide ad hoc financial analysis for strategic decisions.

Skills

Financial modeling
Excel proficiency
Forecasting
Strategic partnering
Communication

Education

Bachelor's degree in Accounting or Finance
MBA or related advanced degree

Tools

ERP systems

Job description

Lyell Immunopharma, Inc. is seeking an Associate Director, FP&A to lead budgeting, forecasting, monthly reporting, and financial modeling in support of a fast‑growing clinical‑stage company.

You will partner with R&D, Clinical, G&A, and Commercial teams to track spend, drive KPI insights, and develop driver‑based models for headcount and program costs, while enhancing FP&A processes and systems.

Get your free, confidential resume review.
or drag and drop your file here.
Similar jobs

Similar jobs worth comparing

Biotech FP&A Associate Director — Budgeting & Forecasting
Biotech FP&A Associate Director — Budgeting & Forecasting

Lyell Immunopharma • South San Francisco (CA)

On-site
USD 170,000 - 210,000
Senior FP&A Director — Biotech (Equity Eligible)
Senior FP&A Director — Biotech (Equity Eligible)

Lyell • South San Francisco (CA), Northern (KY)

Hybrid
USD 170,000 - 210,000
Equity Incentive Plan
Annual Bonus Potential
Senior FP&A Partner for R&D & Strategy
Senior FP&A Partner for R&D & Strategy

Lyell Immunopharma • San Francisco (CA)

On-site
USD 170,000 - 210,000
Equity Incentive Plan
Annual bonus
Associate Director, FP&A
Associate Director, FP&A

Lyell Immunopharma • San Francisco (CA)

On-site
USD 170,000 - 210,000
Equity Incentive Plan
Annual bonus
Associate Director, FP&A
Associate Director, FP&A

Lyell Immunopharma • South San Francisco (CA)

On-site
USD 170,000 - 210,000
Associate Director, FP&A
Associate Director, FP&A

Lyell-Immunopharma,-Inc. • San Francisco (CA)

On-site
USD 170,000 - 210,000
Equity incentive plan
Associate Director, FP&A New South San Francisco, California, United States
Associate Director, FP&A New South San Francisco, California, United States

Lyell • South San Francisco (CA), Northern (KY)

Hybrid
USD 170,000 - 210,000
Equity Incentive Plan
Annual Bonus Potential
Associate Director, FP&A
Associate Director, FP&A

Scorpion Therapeutics • California (MO)

On-site
USD 140,000 - 190,000
Senior FP&A Leader, Commercial Growth (Biotech)
Senior FP&A Leader, Commercial Growth (Biotech)

Cytokinetics, Inc. • United States

Hybrid
USD 201,000 - 234,000
Stock options
Restricted stock units
Health, dental, vision, life and disa​
+3
Strategic FP&A Partner, Commercial Finance (Biotech)
Strategic FP&A Partner, Commercial Finance (Biotech)

Cytokinetics, Inc. • Radnor

Hybrid
USD 201,000 - 234,000
Stock options
Health insurance
401k retirement benefits
+2